ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
Mcfisty
|
538 |
153K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
538
|
153K
|
8
|
|
ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
Mcfisty
|
538 |
153K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
538
|
153K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
Ann: NATO Framework Agreement Signed
|
|
Mcfisty
|
177 |
54K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
177
|
54K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
Ann: NATO Framework Agreement Signed
|
|
Mcfisty
|
177 |
54K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
177
|
54K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
DroneShield (DRO) Discussion Thread
|
|
Mcfisty
|
279 |
92K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
279
|
92K
|
5
|
|
ASX - By Stock
|
DRO |
Re:
DroneShield (DRO) Discussion Thread
|
|
Mcfisty
|
279 |
92K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
279
|
92K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
DroneShield (DRO) Discussion Thread
|
|
Mcfisty
|
279 |
92K |
1 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
279
|
92K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
DroneShield (DRO) Discussion Thread
|
|
Mcfisty
|
279 |
92K |
7 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
279
|
92K
|
7
|
|
ASX - By Stock
|
DRO |
Re:
Ann: DroneShield Recommended by U.S. DoD
|
|
Mcfisty
|
7 |
4.1K |
2 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
7
|
4.1K
|
2
|
|
ASX - By Stock
|
EOS |
Re:
Ann: Update on Financing
|
|
Mcfisty
|
10 |
8.9K |
10 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
10
|
8.9K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Meeting - Chairman's Address & Presentation
|
|
Mcfisty
|
82 |
25K |
16 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
82
|
25K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Meeting - Chairman's Address & Presentation
|
|
Mcfisty
|
82 |
25K |
8 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
82
|
25K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Conference Call Notification
|
|
Mcfisty
|
61 |
15K |
1 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
61
|
15K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Mcfisty
|
62 |
17K |
7 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
62
|
17K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
Mcfisty
|
151 |
50K |
10 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
50K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
Mcfisty
|
126 |
36K |
3 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
36K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough detection patent granted in Australia and Japan
|
|
Mcfisty
|
47 |
14K |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
47
|
14K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Mcfisty
|
132 |
46K |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
132
|
46K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
Mcfisty
|
128 |
51K |
4 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
128
|
51K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Mcfisty
|
687 |
253K |
2 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
253K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Mcfisty
|
687 |
253K |
2 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
253K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
Mcfisty
|
530 |
150K |
5 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
530
|
150K
|
5
|
|
ASX - By Stock
|
SP8 |
Re:
Ann: Emerge divests from Miggster Business for A$5 million
|
|
Mcfisty
|
153 |
40K |
4 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
153
|
40K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Mcfisty
|
213 |
77K |
3 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
213
|
77K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Resapphealth 2022
|
|
Mcfisty
|
214 |
59K |
0 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
214
|
59K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Health Teams to launch ResAppDx on aged care platform
|
|
Mcfisty
|
38 |
10K |
3 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
38
|
10K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough analysis patent granted in China
|
|
Mcfisty
|
87 |
22K |
27 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
87
|
22K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough analysis patent granted in China
|
|
Mcfisty
|
87 |
22K |
1 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
87
|
22K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough analysis patent granted in China
|
|
Mcfisty
|
87 |
22K |
0 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
87
|
22K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough analysis patent granted in China
|
|
Mcfisty
|
87 |
22K |
3 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
87
|
22K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Mcfisty
|
117 |
36K |
1 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
117
|
36K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResAppDx goes live with Doctors on Demand in Australia
|
|
Mcfisty
|
46 |
15K |
3 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
46
|
15K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
COVID-19 Instant Screening test
|
|
Mcfisty
|
1.0K |
294K |
1 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
1.0K
|
294K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: LOI signed with Homify to launch ResAppDx in the Philippines
|
|
Mcfisty
|
29 |
9.0K |
0 |
22/01/22 |
22/01/22 |
ASX - By Stock
|
29
|
9.0K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: LOI signed with Homify to launch ResAppDx in the Philippines
|
|
Mcfisty
|
29 |
9.0K |
4 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
29
|
9.0K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Mcfisty
|
4.6K |
2.1M |
2 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
4.6K
|
2.1M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Distribution agreement with Sanrai International
|
|
Mcfisty
|
25 |
9.1K |
1 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
25
|
9.1K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives $818,826 in R&D tax incentive refund
|
|
Mcfisty
|
10 |
3.5K |
2 |
20/12/21 |
20/12/21 |
ASX - By Stock
|
10
|
3.5K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Mcfisty
|
49 |
12K |
3 |
04/12/21 |
04/12/21 |
ASX - By Stock
|
49
|
12K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Annual General Meeting Presentation
|
|
Mcfisty
|
49 |
12K |
0 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
49
|
12K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives regulatory approvals for cough counter
|
|
Mcfisty
|
23 |
6.8K |
1 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
23
|
6.8K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Publication on challenges of diagnosing respiratory disease
|
|
Mcfisty
|
44 |
12K |
2 |
20/11/21 |
20/11/21 |
ASX - By Stock
|
44
|
12K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Publication on challenges of diagnosing respiratory disease
|
|
Mcfisty
|
44 |
12K |
6 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
44
|
12K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
2021 AGM on 30th November
|
|
Mcfisty
|
6 |
2.0K |
0 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Partnership with Carepath for in-home COPD monitoring
|
|
Mcfisty
|
36 |
9.6K |
4 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
36
|
9.6K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
RAP Overview
|
|
Mcfisty
|
33 |
9.9K |
0 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
33
|
9.9K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: IRB approval for US COVID-19 study modification
|
|
Mcfisty
|
22 |
7.1K |
1 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
22
|
7.1K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
RAP Overview
|
|
Mcfisty
|
33 |
9.9K |
2 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
33
|
9.9K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Hello Dokter...
|
|
Mcfisty
|
20 |
6.9K |
2 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
20
|
6.9K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: COVID-19 Clinical Studies Update
|
|
Mcfisty
|
97 |
32K |
1 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
97
|
32K
|
1
|
|